NCT00668642View on ClinicalTrials.gov

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Prostate Cancer
Interventions
DRUG

Dutasteride

0.5 mg capsule given orally on daily basis

DRUG

Placebo

Identical placebo

Trial Locations (3)

60201

NorthShore University HealthSystem, Evanston

60611

Northwestern University Medical Center, Chicago

60637

University of Chicago Hospitals and Clinics, Chicago

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

Northwestern University

OTHER

lead

Endeavor Health

OTHER

NCT00668642 - Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter